Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access

Atharva Karulkar, Hasmukh Jain, Devanshi Kalra, Smrithi Ravikumar, Anand Vaibhaw, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Neeraj Siddarthan, Pavan Kumar Boyella, Sanket Shah, Sameer Melinkeri, Anshul Gupta, Prashant Mehta, Chandran Nair, Dinesh Bhurani, Akshay Lahoti, Anupam Chakrapani, Balakrishna Padate, Prakash Shekhawat, Priyanka Samal, Rajat Bajaj, Rumesh Chandar, Padmaja Lokireddy, Anil Aribandi, Bhausaheb Bagal, Girish Badarkhe, Jayachandran P.K., Kripa Bajaj, Nataraj KS, Nishad Dhakate, Rajan Kapoor, Rahul Bhargava, Sameer Tulpule, Sharat Damodar, Sunil Gupta, Suraj Chiraniya, Suvir Singh, Rajasekar Thirugnanam, Vasu Babu Goli, Vikram Mathews, Esha Kaul, Krishna Reddy Golamari, Kannan Subramanian, Lingaraj Nayak, Alok Shetty, Aditya Murali, Punit Jain, Rajat Bhattacharyya, Rakesh Boya, Ram Abhinav, Velu Nair, Hari Menon, Monisha Harimadhavan, Mohammed Sadique Ansari, Nishant Tiwari, Shamil Darbar, Supriya Chawkekar, Sushmita Sahay, Manivasagam Sundharam, Ashish Saroha, Moumita Basu, Anjali Jaiswal, Yuktam Yadav, Sakshi Soni, Jayshree Thorat, Shalini Purwar, Nirali Shah, Terry Fry, Nitin Jain, Manju Sengar, Rahul Purwar

Blood (2025) 146 (Supplement 1): 1076.

https://doi.org/10.1182/blood-2025-1076

Published: 2025

Journal Articles

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Anand Vaibhaw, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Sameer Melinkeri, Rahul Bhargava, Neeraj Siddarthan, Dr Dinesh Bhurani, Jayachandran P.K., Esha Kaul, Prashant Mehta, Hari Menon, Bhausaheb Bagal, Kunal Goyal, Prakash Shekhawat, Pavan Kumar Boyella, Rakesh Boya, Ram Abhinav, Rayaz Ahmed, Anil Aribandi, Ashwin V Nair, Chandran Nair, Harish Palaparthi, Lingaraj Nayak, Pawan Singh, Priyanshi Pachauri, Rajat Bhattacharya, Rajiv Kumar, Ranjit Sahoo, Sharat Damodar, Vikram Mathews, Vasu Babu Goli, Abhishek Charan, Ajay Gupta, Amul Kapoor, Anupam Chakrapani, Ashish Bakshi, Bijay Prabhakaran Nair, Bilal Kazi, Debranjani Chattopadhyay, Ganesh S. Jaishetwar, Kaushal Kalra, Kishore Kumar, Lekshmon K.S, Madhav Danthala, Mallikarjun Kalashetty, Narendra Anukonda, Naveen Gupta, Nivedita Dhingra, Padmaja Lokireddy, Prasad Narayanan, Parathan Karunakaran, Prasanth Ganesan, Punit Jain, Priyanka Samal, Ramaswamy N.V., Rajan Kapoor, Shyam Aggarwal, Roy J Palatty, Sainath Bhethanabhotla, Sachin Almel, Santhosh Devadas, Sivakumaran Janakiraman, Sudeep V, Sreeraj Vasudevan, Sameer Tulpule, Suraj Chiraniya, Vijay Patil, Sumita Chaudhry, T Raja, Sunu Cyriac, Shishir Seth, Chezhian Subash, Varun Rajan, Alok Shetty, Vishwanath Sathyanarayanan, Mohammed Sadique Ansari, Nishant Tiwari, Shamil Darbar, Supriya Chawkekar, Sushmita Sahay, Manivasagam Sundharam, Ashish Saroha, Moumita Basu, Anjali Jaiswal, Yuktam Yadav, Sakshi Soni, Jayashree Thorat, Shalini Purwar, Nirali Shah, Terry Fry, Nitin Jain, Sattva Neelapu, Manju Sengar, Rahul Purwar

Blood (2025) 146 (Supplement 1): 6288.

https://doi.org/10.1182/blood-2025-6288

Published: 2025

Journal Articles

Real World Data of FLT3 Mutation Testing Rates Among Indian Patients with Acute Myeloid Leukemia: An AI-Enabled Intervention to Improve Guideline-Compliant Care

Lingaraj Nayak, Anant Gokarn, Prasanth Ganesan, Hari Menon, Nidhi Tandon, Naresh Ramarajan, Vishal Vashistha

Blood (2024) 144 (Supplement 1): 7647.

https://doi.org/10.1182/blood-2024-209677

Published: 2024

Journal Articles

Early Immune Reconstitution Post Allogeneic Transplant and Its Impact on Outcomes According to Type of Transplant

Saswata Saha, Disha Jain, Prashant Tembhare, Nishant Jindal, Puja Ramchandra Bhuibhar, Libin Jacob Mathew, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Anant Gokarn, Sachin Punatar, Bhausaheb Bagal, Sweta Rajpal, Gaurav Chatterjee, Nikhil Patkar, Papagudi Ganesan Subramanian, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 7352.

https://doi.org/10.1182/blood-2024-211122

Published: 2024

Journal Articles

Making Treatment Free Remission “Feasible” in Low- and Middle- Income Countries - Outcomes, Patterns of Failure and Compliance of Treatment Free Remission (TFR) in Chronic Myeloid Leukemia (CML) from a Tertiary Care Cancer Centre in India

Sachin Punatar, Nishant Jindal, Anant Gokarn, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Bhausaheb Bagal, Vinod Hande, Swapnil Chavan, Komal Kumbhalwar, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 3161.

https://doi.org/10.1182/blood-2024-209885

Published: 2024

Journal Articles

Diagnostic Value, Predictive Significance and Kinetics of Fecal Calprotectin in Suspected Acute Gut Gvhd / Gvhd Flare Post Allogeneic Stem Cell Transplant

Sachin Punatar, Lingaraj Nayak, Niket Mantri, Mukta Ramadwar, Prachi Patil, Shaesta Mehta, Aditya Kale, Sridhar Epari, Sridhar Sundaram, Koustubh Shekar, Anant Gokarn, Akanksha Chichra, Sumeet Mirgh, Nishant Jindal, Kalpashree Deval, Libin Jacob Mathew, Bhausaheb Bagal, Hari Menon, Navin Khattry

Blood (2024) 144 (Supplement 1): 4901.

https://doi.org/10.1182/blood-2024-209698

Published: 2024

Journal Articles

Comparison of Various Stem Cell Mobilization Regimens for Multiple Myeloma - a 15-Year Retrospective Institutional Analysis from India

Blood (2023) 142 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2023-182563

Published: 2023

Journal Articles

Molecular Patterns of Resistance in Carbapenem Resistant Organisms Detected in Stool Surveillance Cultures in Patients Undergoing Hematopoietic Cell Transplant

Koustubh Shekar, Akanksha Chichra, Keshav Garg, Sujata Lall, Nishant Jindal, Niket Mantri, Sumeet Mirgh, Lingaraj Nayak, Anant Gokarn, Sachin Punatar, Libin Jacob Mathew, Hari Menon, Vivek Bhat, Navin Khattry

Blood (2023) 142 (Supplement 1): 4918.

https://doi.org/10.1182/blood-2023-184659

Published: 2023

Journal Articles

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Nikhil Patkar, MD, Anam Fatima Shaikh, Chinmayee Kakirde, Rakhi Salve, Prasanna Bhanshe, Gaurav Chatterjee, MD, Sweta Rajpal, Swapnali Joshi, Shruti Chaudhary, Rohan Kodgule, Dhanlaxmi Lalit Shetty, PhD, Hasmukh Jain, MD, Bhausaheb Bagal, MD DM, Hari Menon, MD, Navin Khattry, MD DM, Manju Sengar, MD DM, Prashant Tembhare, MD, Papagudi Ganesan Subramanian, MD, Sumeet Gujral, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-143457

Published: 2020

Journal Articles

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Blood (2018) 132 (Supplement 1): 1498.

https://doi.org/10.1182/blood-2018-99-116837

Published: 2018

Journal Articles

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Blood (2017) 130 (Supplement 1): 5109.

https://doi.org/10.1182/blood.V130.Suppl_1.5109.5109

Published: 2017

Journal Articles

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil Patkar, MD, Devanand Vishwakarma, MSc, Deepan Rajamanickam, MD, Anant Gokarn, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhana Kannan, MSc, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM, Hasmukh Jain, MD, Hari Menon, MD, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, Papagudi Ganesan Subramanian, MD, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 3920.

https://doi.org/10.1182/blood.V130.Suppl_1.3920.3920

Published: 2017

Journal Articles

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Chinmayee Kakirde, Rohan Kodgule, Goutham Raval, Sanjay Talole, Shraddha Kadechkar, Gaurav Chatterjee, Badrinath Yajamanam, Sitaram Ghoghale, Nilesh Deshpande, Pratibha Amare Kadam, PhD, Hari Menon, MD DM., Manju Sengar, Navin Khattry, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Prashant Tembhare, MD, Sumeet Gujral, MD, Nikhil Patkar, MD

Blood (2016) 128 (22): 5249.

https://doi.org/10.1182/blood.V128.22.5249.5249

Published: 2016

Journal Articles

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

Papagudi Ganesan Subramanian, MD, Nikhil Patkar, MD, Prashant Tembhare, MD, Yajamanam Badrinath, Sitaram Ghoghale, Sumeet Gujral, MD, Hari Menon, MD DM, Hasmukh Jain, Bhausaheb Bagal, MD DM, Manju Sengar, Navin Khattry, MD DM

Blood (2016) 128 (22): 5263.

https://doi.org/10.1182/blood.V128.22.5263.5263

Published: 2016

Journal Articles

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Hasmukh Jain, Manju Sengar, Hari Menon, MD DM, Tanuja Shet, MD, Epari Sridhar, MD Pathology, Bhausaheb Bagal, MD DM, Siddhartha Laskar, MD Radiation Oncology, Sumeet Gujral, MD, Navin Khattry, MD DM, Archi Agarwal, Nuclear MD cine, Deepa SUSAN Philip, MD

Blood (2016) 128 (22): 4213.

https://doi.org/10.1182/blood.V128.22.4213.4213

Published: 2016

Journal Articles

Thiopurine Methyl Transferase (TPMT) Activity and Erythrocyte Thioguanine Nucleotide Levels Are Reliable Markers of Tolerability to 6-Mercaptopurine in Adult Acute Lymphoblastic Leukemia

Manju Sengar, MD DM, Murari Gurjar, Anand Patil, Vikram Gota, Hasmukh Jain, MDDM, Hari Menon, MD DM, Uma Dangi

Blood (2015) 126 (23): 3761.

https://doi.org/10.1182/blood.V126.23.3761.3761

Published: 2015

Journal Articles

Prevalence and Clinico-Pathological Attributes of c-MYC Rearranged High-Grade B-Cell Non Hodgkin Lymphomas (NHL): Single Centre Experience

Manju Sengar, MD DM, Sridhar Epari, Hasmukh Jain, MDDM, Tanuja Shet, MD, Sumeet Gujral, MD, Hari Menon, MD DM, Uma Dangi

Blood (2015) 126 (23): 5031.

https://doi.org/10.1182/blood.V126.23.5031.5031

Published: 2015

Journal Articles

Pharmacokinetic and Pharmacodynamic Properties of a Biosimilar Rituximab (Reditux ® ) Are Identical to the Innovator Brand MabThera ® – Experience from a Tertiary Cancer Centre in Western India

Hari Menon, MD DM, Akanksha Yadav, Msc, P.G Subramanian, MD, Manju Sengar, MD DM, Sanhita Rath, MS, Krunal Kavathiya, MPharm, Vikram Gota, MD

Blood (2014) 124 (21): 2246.

https://doi.org/10.1182/blood.V124.21.2246.2246

Published: 2014

Journal Articles

Minimal Residual Disease by Multiparametric Flow Cytometry Predicts Relapse Free Survival better than Over-Expression of WT1 and BAALC in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil V Patkar, MD DNB Clinician Scientist & Asst Professor, Devanand Vishwakarma, MS, Deepen Rajamanickam, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhna Kannan, PhD, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM., Hari Menon, MD DM, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, PG Subramanian, MD, Navin Khattry, MDDM

Blood (2014) 124 (21): 1064.

https://doi.org/10.1182/blood.V124.21.1064.1064

Published: 2014

Journal Articles

Correlation of FDG-PET-CT with Bone Marrow Aspiration and Biopsy at the Initial Staging in Follicular Lymphoma: Can We Omit Bone Marrow Biopsy in Some?

Manju Sengar, MD DM, Hasmukh Jain, MDMDcine, D.M MDcal Oncology, Venkatesh Rangarajan, Archi Agrawal, Hari Menon, MD DM, Sridhar Epari, Tanuja Shet, Sumeet Gujral, MD, Uma Dangi, Siddhartha Laskar, Nehal Khanna

Blood (2014) 124 (21): 4436.

https://doi.org/10.1182/blood.V124.21.4436.4436

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Early use of talicabtagene autoleucel in r/r B-acute lymphoblastic leukemia is cost-effective: Improved efficacy, reduced toxicity and healthcare resource utilization support affordable access

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.

Real World Data of FLT3 Mutation Testing Rates Among Indian Patients with Acute Myeloid Leukemia: An AI-Enabled Intervention to Improve Guideline-Compliant Care

Early Immune Reconstitution Post Allogeneic Transplant and Its Impact on Outcomes According to Type of Transplant

Making Treatment Free Remission “Feasible” in Low- and Middle- Income Countries - Outcomes, Patterns of Failure and Compliance of Treatment Free Remission (TFR) in Chronic Myeloid Leukemia (CML) from a Tertiary Care Cancer Centre in India

Diagnostic Value, Predictive Significance and Kinetics of Fecal Calprotectin in Suspected Acute Gut Gvhd / Gvhd Flare Post Allogeneic Stem Cell Transplant

Comparison of Various Stem Cell Mobilization Regimens for Multiple Myeloma - a 15-Year Retrospective Institutional Analysis from India

Molecular Patterns of Resistance in Carbapenem Resistant Organisms Detected in Stool Surveillance Cultures in Patients Undergoing Hematopoietic Cell Transplant

Molecular Measurable Residual Disease Detection in Acute Myeloid Leukemia Using Error Corrected Next Generation Sequencing

Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome

Presence of Minimal Residual Disease at End of Induction in Acute Myeloid Leukemia Is Predictive of Poor Outcome

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Minimal Residual Disease in Acute Myeloid Leukemia Using a Difference from Normal Approach Is Predictive of Outcome

Plasmacytoid Dendritic Cell Levels at End of Induction Are Predictive of MRD Clearance and Also Influence Disease Outcome in a Subset of Patients

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted R EPOCH Regimen

Thiopurine Methyl Transferase (TPMT) Activity and Erythrocyte Thioguanine Nucleotide Levels Are Reliable Markers of Tolerability to 6-Mercaptopurine in Adult Acute Lymphoblastic Leukemia

Prevalence and Clinico-Pathological Attributes of c-MYC Rearranged High-Grade B-Cell Non Hodgkin Lymphomas (NHL): Single Centre Experience

Pharmacokinetic and Pharmacodynamic Properties of a Biosimilar Rituximab (Reditux ® ) Are Identical to the Innovator Brand MabThera ® – Experience from a Tertiary Cancer Centre in Western India

Minimal Residual Disease by Multiparametric Flow Cytometry Predicts Relapse Free Survival better than Over-Expression of WT1 and BAALC in Acute Myeloid Leukemia

Correlation of FDG-PET-CT with Bone Marrow Aspiration and Biopsy at the Initial Staging in Follicular Lymphoma: Can We Omit Bone Marrow Biopsy in Some?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only